Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Quantum BioPharma Ltd.

    NASDAQ: QNTM · Real-Time Price · USD
    21.36
    1.67 (8.48%)
    At close: Jun 16, 2025, 3:59 PM
    21.51
    0.73%
    Pre-market: Jun 17, 2025, 05:14 AM EDT

    Quantum BioPharma Statistics

    Share Statistics

    Quantum BioPharma has - shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,965

    FTD / Avg. Volume

    n/a
    		 0.33%

    Short Selling Information

    The latest short interest is 99.43K, so 3.42% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 99.43K

    Short % of Shares Out

    n/a
    		 3.42%

    Short % of Float

    n/a
    		 3.53%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.29 and the forward PE ratio is -20.96. Quantum BioPharma's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.29

    Forward PE

    n/a
    		 -20.96

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 4.1

    PB Ratio

    n/a
    		 0.36

    P/FCF Ratio

    n/a
    		 -0.61

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Quantum BioPharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.8, with a Debt / Equity ratio of 0.07.

    Current Ratio

    n/a
    		 1.8

    Quick Ratio

    n/a
    		 1.79

    Debt / Equity

    n/a
    		 0.07

    Debt / EBITDA

    n/a
    		 -0.06

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 -339.16

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 n/a

    Employee Count

    n/a
    		 undefined

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 3.99

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 56.6% in the last 52 weeks. The beta is 1.47, so Quantum BioPharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.47

    52-Week Price Change

    n/a
    		 56.6%

    50-Day Moving Average

    n/a
    		 10.24

    200-Day Moving Average

    n/a
    		 6.38

    Relative Strength Index (RSI)

    n/a
    		 80.66

    Average Volume (20 Days)

    n/a
    		 602,165

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -16.14M

    Net Income

    n/a
    		 -14.2M

    EBITDA

    n/a
    		 -13.69M

    EBIT

    n/a
    		 -14.87M

    Earnings Per Share (EPS)

    n/a
    		 -12.49
    Full Income Statement

    Balance Sheet

    The company has 6M in cash and 824.92K in debt, giving a net cash position of 5.17M.

    Cash & Cash Equivalents

    n/a
    		 6M

    Total Debt

    n/a
    		 824.92K

    Net Cash

    n/a
    		 5.17M

    Retained Earnings

    n/a
    		 -172.11M

    Total Assets

    n/a
    		 14.87M

    Working Capital

    n/a
    		 -412.6K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -6.88M and capital expenditures 1.43, giving a free cash flow of -6.88M.

    Operating Cash Flow

    n/a
    		 -6.88M

    Capital Expenditures

    n/a
    		 1.43

    Free Cash Flow

    n/a
    		 -6.88M

    FCF Per Share

    n/a
    		 -6.05
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    QNTM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for QNTM.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 15, 2024. It was a backward split with a ratio of 1:65.

    Last Split Date

    n/a
    		 Aug 15, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:65

    Scores

    Altman Z-Score

    n/a
    		 -19.61

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist